CB Herald is a news publication agency.

by Joseph Wilson

 Preclinical data show encouraging activity of azenosertib combinations in ADC-resistant TNBC, supporting the potential for pipeline expansion beyond ovarian cancer  Real-world data demonstrate Cyclin E1-positive ovarian cancer patients have significantly worse outcomes, independent of CCNE1 gene amplification status, …

banner

World & Politics

by Joseph Wilson

 Preclinical data show encouraging activity of azenosertib combinations in ADC-resistant TNBC, supporting the potential for pipeline expansion beyond ovarian cancer  Real-world data demonstrate Cyclin E1-positive ovarian cancer patients …

banner
banner
Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?